Cite
HARVARD Citation
Hunt, B. et al. (2017). Evaluating the short-term cost-effectiveness of liraglutide versus lixisenatide in patients with type 2 diabetes in the United States. Journal of medical economics. pp. 1117-1120. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Hunt, B. et al. (2017). Evaluating the short-term cost-effectiveness of liraglutide versus lixisenatide in patients with type 2 diabetes in the United States. Journal of medical economics. pp. 1117-1120. [Online].